Comments
yourfanat wrote: I am using another tool for Oracle developers - dbForge Studio for Oracle. This IDE has lots of usefull features, among them: oracle designer, code competion and formatter, query builder, debugger, profiler, erxport/import, reports and many others. The latest version supports Oracle 12C. More information here.

2008 West
DIAMOND SPONSOR:
Data Direct
SOA, WOA and Cloud Computing: The New Frontier for Data Services
PLATINUM SPONSORS:
Red Hat
The Opening of Virtualization
GOLD SPONSORS:
Appsense
User Environment Management – The Third Layer of the Desktop
Cordys
Cloud Computing for Business Agility
EMC
CMIS: A Multi-Vendor Proposal for a Service-Based Content Management Interoperability Standard
Freedom OSS
Practical SOA” Max Yankelevich
Intel
Architecting an Enterprise Service Router (ESR) – A Cost-Effective Way to Scale SOA Across the Enterprise
Sensedia
Return on Assests: Bringing Visibility to your SOA Strategy
Symantec
Managing Hybrid Endpoint Environments
VMWare
Game-Changing Technology for Enterprise Clouds and Applications
Click For 2008 West
Event Webcasts

2008 West
PLATINUM SPONSORS:
Appcelerator
Get ‘Rich’ Quick: Rapid Prototyping for RIA with ZERO Server Code
Keynote Systems
Designing for and Managing Performance in the New Frontier of Rich Internet Applications
GOLD SPONSORS:
ICEsoft
How Can AJAX Improve Homeland Security?
Isomorphic
Beyond Widgets: What a RIA Platform Should Offer
Oracle
REAs: Rich Enterprise Applications
Click For 2008 Event Webcasts
SYS-CON.TV
Today's Top SOA Links


ICC International Cannabis Corporation Changes its Name to ICC Labs Inc. to Reflect Medicinal and Pharmaceutical Opportunity

VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 12/14/17 -- ICC Labs Inc. ("ICC Labs" or the "Company") (TSX VENTURE: ICC), a fully licensed producer and distributor of medicinal cannabinoid extracts, recreational cannabis and industrial hemp products in Uruguay, is pleased to announce it has changed its name from ICC International Cannabis Corporation. The Company is expected to commence trading under its new name at the opening of trading on the day after it receives final approval from the TSX Venture Exchange (the "TSX-V"). ICC Labs expects to become a leading pharmaceutical grade producer of cannabidiol ("CBD") and other cannabinoid extracts, which will be produced at its cannabinoid extraction laboratory being constructed in Uruguay.

Alejandro Antalich, Chief Executive Officer of ICC, commented: "Our new corporate identity reflects the Company's focus on becoming South America's leading, fully-integrated and low-cost producer of cannabinoid products for medicinal use. As we are growing our own cannabis, and constructing our own extraction laboratory, we will have control over the entire production cycle. Although the first medicinal product that ICC will release to the market is branded CBD oil, 'BIDIOL', our business plan includes a wide range of high-value pharmaceutical and medicinal products from tablets, soft capsules, ointments, creams, drops, syrups to patches. We are seeking to use the highest quality standards to ensure that our lines of product will be available for many medicinal uses. As we've previously announced, ICC Labs is setting up the first cannabinoid extraction laboratory in South America using the Supercritical Fluid CO2 extraction technique with state-of-the-art equipment from Europe. A rendering of the prospective laboratory is currently available here: https://youtu.be/ptszq7pGxBY.

Our continued goal of implementing 'Good Manufacturing Practices' (GMP) in all active pharmaceutical ingredient ("API") manufacturing, and to follow the guidelines of the Food and Drug Administration (FDA), the European Medicines Agency (EMA) and the World Health Organization (WHO), will help to ensure that our API meet the quality and purity characteristics required for medicinal products.

ICC Labs, as a pioneer in the extraction of cannabinoids in Latin America, is in a privileged position when it comes to satisfying the demands of the large South American markets of hundreds of millions of people. Uruguay's geography and position as one of the founding members of the MERCOSUR trading block and its history as an authoritative reference point when it comes to the cannabis industry, puts us in an envious position to develop commercial deals with customers in other South American countries."

The Company's new website can be found at www.icclabs.com.

No action is required to be taken by the Company's shareholders in connection with the name change.

ABOUT ICC LABS INC.

The Company has operations in Uruguay, and is focused on the licensed production, development and sale of medicinal cannabinoid extracts, recreational cannabis and industrial hemp products in Uruguay. For more information, please see the Company's filings on www.sedar.com and www.icclabs.com.

Neither the TSX-V nor its Regulation Services Provider (as that term is defined in the policies of the TSX-V) accepts responsibility for the adequacy or accuracy of this release.

Certain statements in this press release constitute forward-looking information. All statements other than statements of historical fact contained in this press release, including, without limitation, those regarding the Company's future production and sales, results of operations, strategy, plans, objectives, goals and targets, and any statements preceded by, followed by or that include the words "believe", "expect", "aim", "intend", "plan", "continue", "will", "may", "would", "anticipate", "estimate", "forecast", "predict", "project", "seek", "should" or similar expressions or the negative thereof, are forward-looking statements. These statements are not historical facts but instead represent only the Company's expectations, estimates and projections regarding future events. These statements are not guarantees of future performance and involve assumptions, risks and uncertainties that are difficult to predict. Therefore, actual results may differ materially from what is expressed, implied or forecasted in such forward-looking statements.

Additional factors that could cause actual results, performance or achievements to differ materially include, but are not limited to: the Company's ability to complete the construction of its cannabinoid extraction laboratory in a timely fashion and in accordance with requisite regulatory requirements, or at all, to obtain all requisite regulatory approvals for the production and export of cannabinoid based products and to produce various cannabinoid based products in a cost-effective manner, or at all. Additional information identifying risks and uncertainties is contained in the Company's filings with Canadian securities regulators, and available at www.sedar.com. Management provides forward-looking statements because it believes they provide useful information to investors when considering their investment objectives and cautions investors not to place undue reliance on forward-looking information. Consequently, all of the forward-looking statements made in this press release are qualified by these cautionary statements and other cautionary statements or factors contained herein, and there can be no assurance that the actual results or developments will be realized or, even if substantially realized, that they will have the expected consequences to, or effects on, the Company. These forward-looking statements are made as of the date of this press release and the Company assumes no obligation to update or revise them to reflect subsequent information, events or circumstances or otherwise, except as required by law.

Contacts:
ICC Labs Inc.
Alejandro Antalich
Chief Executive Officer
598-2900-0000
ir@icclabs.com

About Marketwired .
Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.

Web 2.0 Latest News
While walking around the office I happened upon a relatively new employee dragging emails from his inbox into folders. I asked why and was told, “I’m just answering emails and getting stuff off my desk.” An empty inbox may be emotionally satisfying to look at, but in practice, you shou...
An update to the Web Content Accessibility Guidelines (WCAG) is coming. Did I lose you already? If you're not familiar with WCAG, it's a collection of guidelines that developers, designers and accessibility experts use to help ensure the apps and websites they create are accessible to ...
Hiring a digital marketer starts as soon as you plan to launch a prototype of your innovative idea. But, without knowing anything about digital marketing, you may not be able to reach out to investors and target audiences. You can follow the following basic points to know the significa...
Java 9 ships with some minor—yet awesome—new language features that make developing easier and cleaner. In this post, we’ll take a look at three of these new features. You probably remember interface methods, which were introduced in Java 8. These are required so that Java itself, as ...
Digital transformation has changed the way users interact with the world, and the traditional healthcare experience no longer meets rising consumer expectations. Enterprise Health Clouds (EHCs) are designed to easily and securely deliver the smart and engaging digital health experience...
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
Click to Add our RSS Feeds to the Service of Your Choice:
Google Reader or Homepage Add to My Yahoo! Subscribe with Bloglines Subscribe in NewsGator Online
myFeedster Add to My AOL Subscribe in Rojo Add 'Hugg' to Newsburst from CNET News.com Kinja Digest View Additional SYS-CON Feeds
Publish Your Article! Please send it to editorial(at)sys-con.com!

Advertise on this site! Contact advertising(at)sys-con.com! 201 802-3021




SYS-CON Featured Whitepapers
ADS BY GOOGLE